Drospirenone
2 NDCs across 1 manufacturer|0 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on May 23, 2019. In 2024, Medicare Part D spent $2 million on Drospirenone across 6,063 claims for 1,718 beneficiaries.
Drospirenone is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $6.61 to $6.61 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$6.61 – $6.61
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Exeltis USA, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing DROSPIRENONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SLYND 4 MG TABLET | $6.6125 per EA | 0.00% |
SLYND 4 MG TABLET | $6.6125 per EA | 0.00% |
Frequently Asked Questions
How much does Medicare spend on Drospirenone?
In 2024, Medicare Part D spent $2 million on Drospirenone across 6,063 claims for 1,718 beneficiaries.
How many Drospirenone products are on the market?
The Drospirenone drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Drospirenone?
NADAC reference prices for Drospirenone range from $6.6125 to $6.6125 per EA.
Which manufacturers make Drospirenone?
1 manufacturer lists Drospirenone in NADAC. Ranked by number of NDCs, the largest are Exeltis USA, Inc. (2).
How has the price of Drospirenone changed recently?
Over the past 7 days, 0 Drospirenone NDCs rose and 0 fell, with a market-wide average change of +0.0%.